A systematic review of the use of bacteriophages for in vitro biofilm control

dc.commentsCEB56346por
dc.contributor.authorMeneses, Lucianapor
dc.contributor.authorBrandão, Ana Catarinapor
dc.contributor.authorCoenye, Tompor
dc.contributor.authorBraga, A. C.por
dc.contributor.authorPires, Diana Priscila Pensopor
dc.contributor.authorAzeredo, Joanapor
dc.date.accessioned2023-07-20T09:35:40Z
dc.date.available2023-07-20T09:35:40Z
dc.date.issued2023-07-05
dc.date.updated2023-07-19T21:24:10Z
dc.descriptionThe online version contains supplementary material available at: https://doi.org/10.1007/s10096-023-04638-1por
dc.description.abstractBacteriophages (phages) are very promising biological agents for the prevention and control of bacterial biofilms. However, little is known about the parameters that can influence the efficacy of phages on biofilms. This systematic review provides a summary and analysis of the published data about the use of phages to control pre-formed biofilms in vitro, suggesting recommendations for future experiments in this area. A total of 68 articles, containing data on 605 experiments addressing the efficacy of phages to control biofilms in vitro were included, after a search conducted in Web of Science, Embase, and Medline (PubMed). The data collected from each experiment included information about biofilm growth conditions, phage characteristics, treatment conditions and biofilm reduction. In most cases, biofilms were formed in the surface of microtiter plates (82.5\%); the median time for biofilm formation was 24 h, as is the median treatment duration. Quantification of biofilm biomass (52.6\%), viable cells (25.5\%) and metabolic activity (17.9\\%) were the most common biofilm assessment methods. Correlation analysis revealed that some phage parameters can influence the treatment outcome: higher phage concentrations were strongly associated with improved biofilm control, leading to higher levels of biofilm reduction, and phages with higher burst sizes and shorter latent periods seem to be the best candidates to control biofilms in vitro. However, the great variability of the methodologies used prompts the need for the development of standardized in vitro methodologies to characterize phage/biofilm interactions and to assess the efficacy of phages to control biofilms.por
dc.description.publicationversioninfo:eu-repo/semantics/publishedVersion
dc.description.sponsorshipOpen access funding provided by FCT|FCCN (b-on). The authors acknowledge the support by the Portuguese Foundation for Science and Technology (FCT) under the scope of the strategic funding of UIDB/04469/2020 unit. L.M. also acknowledges the fnancial support from FCT through the PhD grant SFRH/BD/07494/2020. This study has been funded by a Research Grant 2022 of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) to D.P.P.por
dc.distributioninternationalpor
dc.identifier.citationMeneses, L., Brandão, A. C., Coenye, T., Braga, A. C., Pires, D. P., & Azeredo, J. (2023, July 5). A systematic review of the use of bacteriophages for in vitro biofilm control. European Journal of Clinical Microbiology & Infectious Diseases. Springer Science and Business Media LLC. http://doi.org/10.1007/s10096-023-04638-1por
dc.identifier.doi10.1007/s10096-023-04638-1por
dc.identifier.issn0934-9723por
dc.identifier.pmid37407800por
dc.identifier.urihttps://hdl.handle.net/1822/85584
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherSpringer Naturepor
dc.relationinfo:eu-repo/grantAgreement/FCT/6817 - DCRRNI ID/UIDB%2F04469%2F2020/PTpor
dc.relationSFRH/BD/07494/2020por
dc.relation.publisherversionhttp://www.springer.com/biomed/medical+microbiology/journal/10096por
dc.rightsopenAccesspor
dc.subjectBacteriophagespor
dc.subjectBiofilmpor
dc.subjectIn vitropor
dc.subjectSystematic reviewpor
dc.titleA systematic review of the use of bacteriophages for in vitro biofilm controlpor
dc.typearticle
dspace.entity.typePublicationen
oaire.citationConferencePlaceGermany
oaire.citationEndPage928por
oaire.citationIssue8por
oaire.citationStartPage919por
oaire.citationVolume42por
sdum.journalEuropean Journal of Clinical Microbiology & Infectious Diseasespor

Ficheiros

Pacote original

A mostrar 1 - 1 de 1
A carregar...
Nome:
document_56346_1.pdf
Tamanho:
1.22 MB
Formato:
Adobe Portable Document Format